Study on the Present Situation of China's Skin Disease Drug Market
In China, skin disease is a common and frequent disease. Total incidence of skin disease in China is 1.23%, i.e. about 16 million people, which means there is huge market room for skin disease drug. This report analyzes the market scale, market segmentation of skin disease drug and key drug varieties, and it pointedly puts forward marketing suggestions.
1 MARKET SCALE
2 MARKET SEGMENTATION
2.1 Analysis of market share of various types of skin disease drugs
2.2 Analysis of market share of various varieties of skin disease drugs
2.3 Analysis of market share of various manufacturers of skin disease drugs
3 MARKET ANALYSIS OF KEY VARIETIES OF SKIN DISEASE DRUGS
3.1 Terbinafine
3.2 Povidone Iodine
3.3 Iodized Lecithin
3.4 Hydrocortisone Butyrate
3.5 Retimid-ester
3.6 Five types of major antifungal drugs
4 MARKETING SUGGESTIONS
2 MARKET SEGMENTATION
2.1 Analysis of market share of various types of skin disease drugs
2.2 Analysis of market share of various varieties of skin disease drugs
2.3 Analysis of market share of various manufacturers of skin disease drugs
3 MARKET ANALYSIS OF KEY VARIETIES OF SKIN DISEASE DRUGS
3.1 Terbinafine
3.2 Povidone Iodine
3.3 Iodized Lecithin
3.4 Hydrocortisone Butyrate
3.5 Retimid-ester
3.6 Five types of major antifungal drugs
4 MARKETING SUGGESTIONS
